RITUXAN Safety Questions, RITUXAN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about RITUXAN. Our extensive database of RITUXAN adverse events and RITUXAN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about RITUXAN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




RITUXAN Safety Reports

Total RITUXAN reports: 848.
RITUXAN FDA safety alerts: 2004 2006 .
Reported deaths: 139    Reported hospitalizations: 371.
Take RITUXAN Side Effects Survey or Share Your RITUXAN Story. RITUXAN Usage.

Showing 1-75 of 848 Next >

Health Professional from JAPAN reported RITUXAN problem on Feb 23, 2007. Male patient, 69 years of age, weighting 154.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastric cancer, lymphadenopathy, no therapeutic response. RITUXAN dosage: 375 MG, UNK, INTRAVENOUS. During the same period patient was treated with ZEVALIN, CLADRIBINE, CYCLOPHOSPHAMIDE, PREDNISOLONE, PROCARBAZINE. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Pharmacist from UNITED STATES on Mar 09, 2007. Female patient, weighting 244.7 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: chills, dyspnoea, infusion related reaction, muscle spasms, pain in extremity, pyrexia. RITUXAN dosage: 800 MG X1 IV DRIP. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Feb 23, 2007. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: 640 MG, QD INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, METHYLCOBALAMIN, HYTRIL, LAFUTIDINE. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Physician from JAPAN on Feb 23, 2007. Male patient, 68 years of age, weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, gastric ulcer, gastrointestinal haemorrhage, haemoglobin decreased, helicobacter infection. RITUXAN dosage: 375 MG, QD, INTRAVENOUS. During the same period patient was treated with FERROMIA, LASIX, ALDACTONE, URSO, OCTOTIAMINE, ASPARA, CHINESE MEDICINE, MOSAPRIDE CITRATE. Patient recovered.

Physician from UNITED STATES reported RITUXAN problem on Mar 02, 2007. Female patient, 39 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, chills, culture urine positive, knee arthroplasty, nephrolithiasis, pyrexia. RITUXAN dosage: 1000 MG, X2, INTRAVENOUS. During the same period patient was treated with LEVAQUIN. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Physician from UNITED STATES on Feb 26, 2007. Female patient, 72 years of age, weighting 226.4 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, blood glucose increased, coronary artery occlusion. RITUXAN dosage: 1000 MG, DAYS 1+5, INTRAVENOUS. During the same period patient was treated with ALTACE, TOPROL, NORVASC, METHOTREXATE, FOLATE, GLIPIZIDE, METFORMIN, LIPITOR. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported RITUXAN problem on Mar 01, 2007. Male patient, 64 years of age, weighting 127.9 lb, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, lung infiltration, pleural effusion, pulmonary toxicity. RITUXAN dosage: 630 MG Q3W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Health Professional from JAPAN on Feb 27, 2007. Male patient, 65 years of age, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, gastric cancer, gastritis erosive, immune system disorder, lymphocyte count decreased. RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, BIOFERMIN, METHYLCOBAL, RILMAZAFONE HYDROCHLORIDE, AMLODIPINE BESYLATE, SENNA LEAF, SUCRALFATE, ETIZOLAM. Patient was hospitalized. Patient recovered.

Health Professional from JAPAN reported RITUXAN problem on Feb 27, 2007. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pancreatitis. RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient recovered.

RITUXAN problem was reported by a Physician from CANADA on Feb 27, 2007. Female patient was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Feb 27, 2007. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, hemiplegia. RITUXAN dosage: 375 MG, QD, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE. Patient recovered.

RITUXAN problem was reported by a Physician from JAPAN on Feb 27, 2007. Female patient, 71 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, blood pressure decreased, bronchopulmonary aspergillosis, culture urine positive, cytomegalovirus infection, cytomegalovirus urinary tract infection, enterococcal infection, herpes zoster. RITUXAN dosage: 532 MG, QD; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died on 12/01/2006.

Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 01, 2007. Male patient, 87 years of age, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, infusion site reaction, loss of consciousness, pulse absent, transient ischaemic attack, urinary incontinence, white blood cell count increased. RITUXAN dosage: 600 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with DECADRON, TYLENOL, BENADRYL. Patient recovered.

RITUXAN problem was reported by a Health Professional from UNITED STATES on Feb 27, 2007. Male patient was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased. RITUXAN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Female patient was diagnosed with sjogren's syndrome and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis. RITUXAN dosage: 100 MG,X2, INTRAVENOUS. Patient recovered.

RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Female patient, 28 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abortion induced, platelet count decreased, pregnancy. RITUXAN dosage: 600 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with IMMUNE GLOBULIN, PREDNISOLOLNE. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Feb 28, 2007. Female patient, 69 years of age, weighting 83.78 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: asthma, vomiting. RITUXAN dosage: 480 MG, INTRAVENOUS. During the same period patient was treated with ENDOAN, DOXORUBICIN, ONCOVIN, PREDONINE, ADALAT, LISINOPRIL, FAMOTIDINE, ALLOPURINOL. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Physician from JAPAN on Mar 01, 2007. Female patient, 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: adrenal insufficiency, anorexia, asthenia, autonomic nervous system imbalance, blood potassium increased, blood pressure decreased, dehydration, diplopia, electrolyte imbalance. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ALFAROL, MAGNESIUM OXIDE, ISONIAZID, ITRIZOLE, ZOLPIDEM TARTRATE, SULFAMETHOXAZOLE, POLAPREZINC. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported RITUXAN problem on Mar 02, 2007. Female patient, 41 years of age, weighting 123.5 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood chloride decreased, blood lactate dehydrogenase increased, neutrophil count increased, platelet count increased, viral myocarditis, white blood cell count increased. RITUXAN dosage: 1000 MG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE, PREDNISONE, METHOTREXATE, NAPROXEN, FOLIC ACID, TYLENOL #, LORTAB. Patient died on 09/21/2006.

RITUXAN problem was reported by a Physician from UNITED STATES on Mar 02, 2007. Male patient, 60 years of age, weighting 252.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: dehydration, fatigue, pyrexia. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Male patient, 63 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: anaemia, lung disorder, no therapeutic response, t-cell lymphoma. RITUXAN dosage: 375 MG/M2. During the same period patient was treated with PENTOSTATIN, CYCLOPHOSPHAMIDE, ACETAMINOPHEN, DIPHENHYDRAMINE, HYDROCORTISONE, MEPERIDINE, ONDANSETRON, PROMETHEZINE. Patient recovered.

RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2007. Male patient, 80 years of age, was diagnosed with neoplasm malignant and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anorexia, dizziness, dry mouth, fatigue, neoplasm progression. RITUXAN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Female patient, 59 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: infusion related reaction, polyarthritis. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2007. Male patient, 54 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: arthritis. RITUXAN dosage: unknown. During the same period patient was treated with PREDNISONE, IMURAN, ASPIRIN, PRILOSEC, TYLENOL, CODEINE SUL. Patient recovered.

Physician from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, condition aggravated, rheumatoid arthritis. RITUXAN dosage: 100 MG, SINGLE, INTRAVENOUS. Patient recovered.

RITUXAN problem was reported by a Physician from UNITED STATES on Mar 10, 2007. Female patient, 43 years of age, weighting 142.0 lb, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: complication of pregnancy. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with EFFEXOR, XANAX, GABAPENTIN. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Feb 28, 2007. Male patient, 71 years of age, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. RITUXAN dosage: unknown. During the same period patient was treated with STEROID, GLOBULIN NOS. Patient died.

RITUXAN problem was reported by a Physician from JAPAN on Mar 10, 2007. Male patient, 56 years of age, weighting 105.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: femoral neck fracture, lumbar vertebral fracture, red blood cell count decreased, white blood cell count decreased. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, ETOPOSIDE. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Mar 10, 2007. Male patient, 79 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: hepatic necrosis, jaundice, liver disorder, pyrexia. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PIRARUBICIN, VINDESINE, PREDNISOLONE, URSODESOXYCHOLIC ACID, PANTETHINE, MAGNESIUM OXIDE, TRICHLORMETHIAZIDE. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, 65 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastric cancer. RITUXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, METHYLPREDNISOLONE, CYTARABINE, CISPLATIN. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Mar 06, 2007. Male patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: oesophageal carcinoma. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

RITUXAN problem was reported by a Physician from JAPAN on Mar 01, 2007. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, depressed level of consciousness, hepatitis b, urine output decreased. RITUXAN dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, CLARITIN, IBUPROFEN, REASTAMIN, VOLTAREN. Patient died on 01/09/2007.

Physician from JAPAN reported RITUXAN problem on Mar 01, 2007. Male patient, 59 years of age, weighting 130.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, obstruction gastric, pancreatic disorder. RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2007. Female patient, 78 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abnormal faeces, chest discomfort, fatigue, international normalised ratio increased, platelet count decreased. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Female patient, 27 years of age, was diagnosed with central nervous system lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: bradycardia. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with TEMODAR. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma recurrent, bile duct cancer. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Mar 04, 2007. Male patient, 68 years of age, weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: anaemia, gastric ulcer, gastrointestinal haemorrhage, helicobacter infection, hepatic failure, tumour lysis syndrome. RITUXAN dosage: 375 MG, QD, INTRAVENOUS. During the same period patient was treated with FERROMIA, LASIX, ALDACTONE, URSO, OCTOTIAMINE, ASPARA, CHINESE MEDICINE, MOSAPRIDE CITRATE. Patient recovered.

RITUXAN problem was reported by a Physician from NORWAY on Mar 07, 2007. Female patient, 49 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHASPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.

Physician from UNITED KINGDOM reported RITUXAN problem on Mar 14, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: atelectasis, c-reactive protein increased, chest pain, haemoglobin decreased, hypoxia, lymphocyte count decreased, neutrophil count decreased, pericardial rub, pleuritic pain. RITUXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, FOLIC ACID, ALENDRONATE, CALCICHEW DE, AMITRIPRYLINE, KETOPROFEN. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Physician from NORWAY on Mar 07, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISOLONE. Patient recovered.

Health Professional from NORWAY reported RITUXAN problem on Mar 07, 2007. Female patient, 30 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.

RITUXAN problem was reported by a Health Professional from NORWAY on Mar 07, 2007. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.

Pharmacist from JAPAN reported RITUXAN problem on Mar 07, 2007. Male patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: oesophageal carcinoma. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

RITUXAN problem was reported by a Health Professional from NORWAY on Mar 07, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.

Physician from UNITED STATES reported RITUXAN problem on Mar 06, 2007. Female patient, 84 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: aplasia, bone marrow failure. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, PANTOPRAZOLE, AMLODIPINE BESYLATE, CLONAZEPAM, ACYCLOVIR. Patient recovered.

RITUXAN problem was reported by a Physician from UNITED STATES on Mar 09, 2007. Female patient, 65 years of age, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. RITUXAN dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 08, 2007. Female patient, 67 years of age, weighting 134.9 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gallbladder operation. RITUXAN dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 59 years of age, weighting 131.0 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: air-borne transmission. RITUXAN dosage: unknown. During the same period patient was treated with PREMPRO, OXYCONTIN, FOLIC ACID, OXYCODONE, WELLBUTRIN, EFFEXOR, CYMBALTA, NEURONTIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported RITUXAN problem on Mar 09, 2007. Female patient, 72 years of age, weighting 226.4 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, blood glucose increased, coronary artery occlusion. RITUXAN dosage: 1000 MG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with ALTACE, TOPROL, NORVASC, METHOTREXATE, FOLATE, GLIPIZIDE, METFORMIN, LIPITOR. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Physician from NORWAY on Mar 07, 2007. Female patient, 58 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISOLONE. Patient recovered.

Physician from GERMANY reported RITUXAN problem on Mar 13, 2007. Male patient, child 2 years of age, weighting 4.41 lb, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: herpes sepsis, herpes zoster, hypogammaglobulinaemia, intestinal functional disorder, lung disorder, meningeal disorder, pneumonia parainfluenzae viral. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISOLONE, DAPSONE. Patient recovered.

RITUXAN problem was reported by a Health Professional from GERMANY on Mar 13, 2007. Female patient, 81 years of age, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumonia bacterial, pulmonary embolism. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. Patient recovered.

Health Professional from GERMANY reported RITUXAN problem on Mar 13, 2007. Female patient, 63 years of age, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastroenteritis clostridial, intestinal functional disorder, pneumonia. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE. Patient recovered.

RITUXAN problem was reported by a Pharmacist from UNITED STATES on Mar 23, 2007. Female patient, weighting 118.6 lb, was diagnosed with graft thrombosis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, air embolism, arteriosclerosis coronary artery, chest pain, infusion related reaction, pericardial effusion, pleural effusion, sepsis syndrome, shock. RITUXAN dosage: 33.3 MG ONCE IV DRIP. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from GERMANY reported RITUXAN problem on Mar 13, 2007. Female patient, 63 years of age, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: clostridial infection, pneumonia bacterial. RITUXAN dosage: 375 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE. Patient died.

RITUXAN problem was reported by a Physician from UNITED STATES on Mar 14, 2007. Female patient, 55 years of age, was diagnosed with dermatomyositis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: arrhythmia. RITUXAN dosage: 1000 MG, INTRAVENOUS. Patient died on 03/10/2007.

Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 14, 2007. Male patient, 67 years of age, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, ejection fraction decreased, fluid retention, palpitations, weight increased. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE, DEXAMETHASONE, CYTARABINE, LEUCOVORIN CALCIUM, BICARBONATE IN PLASTIC CONTAINER. Patient recovered.

RITUXAN problem was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Female patient, 60 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cholelithiasis. RITUXAN dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with FOLIC ACID, METHOTREXATE, PRILOSEC, ZYRTEC, ACTONEL, LORTAB, ULTRAM, CELEBREX. Patient was hospitalized. Patient recovered.

Physician from CANADA reported RITUXAN problem on Mar 14, 2007. Female patient was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, lung disorder. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Physician from JAPAN on Mar 15, 2007. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: prepyloric stenosis. RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE. Patient recovered.

Physician from CANADA reported RITUXAN problem on Mar 19, 2007. Female patient, 59 years of age, weighting 143.3 lb, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cellulitis, neutropenia. RITUXAN dosage: 375 MG/M2, UNK; INTRAVENOUS. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Female patient, 71 years of age, weighting 162.0 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, surgery. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported RITUXAN problem on Mar 23, 2007. Female patient, 40 years of age, was diagnosed with systemic lupus erythematosus and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: systemic lupus erythematosus. RITUXAN dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE, DURAGESIC, FOSAMAX, ZOFRAN, NORTRIPTYLIN. Patient recovered.

RITUXAN problem was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. RITUXAN dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with LISINOPRIL, PROTONIX, PREDNISONE. Patient was hospitalized. Patient recovered.

Physician from CANADA reported RITUXAN problem on Mar 20, 2007. Male patient, 84 years of age, weighting 134.5 lb, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: anuria, chills, hypotension. RITUXAN dosage: 640 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE. Patient recovered.

RITUXAN problem was reported by a Physician from JAPAN on Mar 23, 2007. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: peritonitis. RITUXAN dosage: 570 MG, SINGLE; INTRAVENOUS, 560 MG, SINGLE; INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, PARAPLATIN, ETOPOSIDE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Mar 19, 2007. Female patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, diffuse large b-cell lymphoma recurrent. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Health Professional from RUSSIAN FEDERATION on Mar 23, 2007. Male patient, 72 years of age, weighting 181.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cavernous sinus thrombosis, sinusitis. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, AMOXICLAV. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported RITUXAN problem on Dec 27, 2006. Female patient, 28 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: caesarean section, pre-eclampsia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

RITUXAN problem was reported by a Physician from JAPAN on Dec 27, 2006. Female patient, 72 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: arthralgia, gait disturbance, joint swelling, osteonecrosis. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADIRACIN, ONCOVIN, PREDNISOLONE, VEPESID. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Feb 28, 2007. Male patient, 71 years of age, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. RITUXAN dosage: unknown. During the same period patient was treated with STEROID, GLOBULIN NOS. Patient died.

RITUXAN problem was reported by a Physician from JAPAN on Mar 10, 2007. Male patient, 56 years of age, weighting 105.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: femoral neck fracture, lumbar vertebral fracture, red blood cell count decreased, white blood cell count decreased. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, ETOPOSIDE. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Mar 10, 2007. Male patient, 79 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: hepatic necrosis, jaundice, liver disorder, pyrexia. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PIRARUBICIN, VINDESINE, PREDNISOLONE, URSODESOXYCHOLIC ACID, PANTETHINE, MAGNESIUM OXIDE, TRICHLORMETHIAZIDE. Patient was hospitalized. Patient recovered.

RITUXAN problem was reported by a Physician from JAPAN on Mar 06, 2007. Male patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: oesophageal carcinoma. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Physician from JAPAN reported RITUXAN problem on Mar 01, 2007. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, depressed level of consciousness, hepatitis b, urine output decreased. RITUXAN dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, CLARITIN, IBUPROFEN, REASTAMIN, VOLTAREN. Patient died on 01/09/2007.

Showing 1-75 of 848 Next >

Ask Our Patient Community about RITUXAN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
Monopril</